# Avenio

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/avenio
- **Dataset:** https://optimly.ai/brand/avenio.json
- **Markdown:** https://optimly.ai/brand/avenio/llms.txt
- **Official website:** https://avenio.ai
- **Slug:** avenio
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Avenio is AI-native, meaning intelligence is built into the protocol itself rather than AI being a bolted-on feature. It's trained on over 25,000 protocols and 70B+ clinical parameters, offers deterministic and low-hallucination outputs, and is compliant by design (ICH/FDA aligned, 21 CFR Part 11 audit trail, data isolation ensuring client data is not used for model training). Features include AI-guided drafting, collaborative workspace, and Risk Radar for surfacing inconsistencies and risks.
Source: Brand's website (https://avenio.ai) · 2026-10-04

- **Description:** Avenio provides an AI-native intelligent workspace, the Intelligent Protocol Hub, designed to accelerate the creation of compliant, submission-ready clinical protocols from design through lifecycle. It aims to reduce authoring time, amendments, and risks, leading to faster first-patient-in timelines for clinical trials.
Source: Brand's website (https://avenio.ai) · 2026-10-04

## Offerings

- **Core capabilities:** Intelligent Protocol Hub
Source: Brand's website (https://avenio.ai) · 2026-10-04

- **Pricing:** Not explicitly mentioned, likely subscription-based.
Source: Brand's website (https://avenio.ai) · 2026-10-04

## Audience

- **Target industry:** Clinical development teams, medical writers, regulatory affairs, and biostatisticians within life sciences and pharmaceutical organizations.
Source: Brand's website (https://avenio.ai) · 2026-10-04

Page last updated 2026-10-17.